Analysis and predictions INFU vs ROSC
Loading...
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INFU is a Buy and ROSC is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INFU’s FA Score shows that 0 FA rating(s) are green while.
- INFU’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INFU’s TA Score shows that 3 TA indicator(s) are bullish.
- INFU’s TA Score: 3 bullish, 2 bearish.
Price Growth
INFU (@Medical Specialties) experienced а 0.00% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +2.86%. For the same industry, the average monthly price growth was -1.00%, and the average quarterly price growth was +16.07%.
Reported Earning Dates
INFU is expected to report earnings on Aug 15, 2024.
Industries' Descriptions
@Medical Specialties (+2.86% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
INFU | ||
|---|---|---|
OUTLOOK RATING 1..100 | 67 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 89 Overvalued | |
PROFIT vs RISK RATING 1..100 | 75 | |
SMR RATING 1..100 | 88 | |
PRICE GROWTH RATING 1..100 | 79 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| INFU | ROSC | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 72% | 1 day ago 81% |
| Momentum ODDS (%) | N/A | 1 day ago 88% |
| MACD ODDS (%) | 1 day ago 75% | 1 day ago 85% |
| TrendWeek ODDS (%) | 1 day ago 75% | 1 day ago 81% |
| TrendMonth ODDS (%) | 1 day ago 77% | 1 day ago 75% |
| Advances ODDS (%) | N/A | 3 days ago 81% |
| Declines ODDS (%) | 8 days ago 73% | 8 days ago 75% |
| BollingerBands ODDS (%) | 1 day ago 71% | 1 day ago 86% |
| Aroon ODDS (%) | 1 day ago 70% | 1 day ago 78% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSDUX | 12.90 | 0.08 | +0.62% |
| Morgan Stanley Emerging Mkt ex China I | |||
| PWJDX | 29.84 | 0.16 | +0.54% |
| PGIM Jennison International Opps R4 | |||
| SUICX | 48.75 | 0.13 | +0.27% |
| DWS CROCI International C | |||
| EAALX | 20.25 | 0.05 | +0.25% |
| Eaton Vance Atlanta Capital Focused Gr A | |||
| JHJIX | 22.65 | -0.01 | -0.04% |
| JHancock ESG Large Cap Core I | |||
INFU and
Correlation & Price change
A.I.dvisor tells us that INFU and VCYT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INFU and VCYT's prices will move in lockstep.
| Ticker / NAME | Correlation To INFU | 1D Price Change % | ||
|---|---|---|---|---|
| INFU | 100% | -1.75% | ||
| VCYT - INFU | 32% Poorly correlated | +0.35% | ||
| XRAY - INFU | 30% Poorly correlated | +0.19% | ||
| NVST - INFU | 30% Poorly correlated | +0.30% | ||
| SMTI - INFU | 29% Poorly correlated | -0.31% | ||
| BIO - INFU | 28% Poorly correlated | -2.48% | ||
More | ||||
ROSC and
Correlation & Price change
A.I.dvisor tells us that ROSC and SXC have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ROSC and SXC's prices will move in lockstep.
| Ticker / NAME | Correlation To ROSC | 1D Price Change % | ||
|---|---|---|---|---|
| ROSC | 100% | -0.04% | ||
| SXC - ROSC | 17% Poorly correlated | -2.99% | ||
| EZPW - ROSC | 13% Poorly correlated | +0.26% | ||
| CORT - ROSC | 12% Poorly correlated | -2.26% | ||
| IRMD - ROSC | 12% Poorly correlated | +1.29% | ||
| PLAB - ROSC | 11% Poorly correlated | +2.04% | ||
More | ||||